LYTTON LAURENCE W → Retension Pharmaceuticals, Inc. RTSN

Stake: — Shares: — Class: Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

2 transactions

2 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-10-08	BERENDT MICHAEL J	director	Award	5,636	$12.00	$68K
2026-10-08	Olds Donald	director	Award	5,636	$12.00	$68K

Other 13D/G Filings on Retension Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2026-10-16	SCHEDULE 13G	B Group, Inc.	—	—	view →
2026-10-16	SCHEDULE 13G	PVG ASSET MANAGEMENT CORP	—	—	view →
2026-10-14	SCHEDULE 13D	Keller Eric L.	7.07%	598,598	view →

Other Filings by LYTTON LAURENCE W

Filed	Form	Issuer	Stake	Shares
2026-10-05	SCHEDULE 13G	Birchtech Corp.	—	—	view →
2026-08-20	SCHEDULE 13G	Rank One Computing Corp	—	—	view →
2026-06-23	SCHEDULE 13G	DATA I/O CORP DAIO	—	—	view →
2026-06-09	SCHEDULE 13G	Sintx Technologies, Inc. SINT	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →